Concepedia

Holly Branthoover

HB

Statistics

Publications

5

Citations

132

H-Index

5

Active since

2021

Affiliations

Moffitt Cancer Center(Current)

University of South Florida

Holly Branthoover is an author at Moffitt Cancer Center specializing in immunology, cancer immunology, and oncology.

ORCID

Publications per year

2021–2024

5

Publications

5

Combination Nivolumab, CD137 Agonism, and Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes for Patients with Metastatic Melanoma

MacLean Hall, John E. Mullinax, Cheryl A. Cox et al. · Clinical Cancer Research · 2022 · 40 citations · Full text

, , +17

Neoantigen-specific CD4<sup>+</sup> tumor-infiltrating lymphocytes are potent effectors identified within adoptive cell therapy products for metastatic melanoma patients

MacLean Hall, Jamie K. Teer, Xiaoqing Yu et al. · Journal for ImmunoTherapy of Cancer · 2023 · 36 citations · Full text

, , +17

Expansion of tumor-infiltrating lymphocytes (TIL) from penile cancer patients

Ahmet Murat Aydın, MacLean Hall, Brittany Bunch et al. · International Immunopharmacology · 2021 · 33 citations · Full text

, , +14

Tamm-Horsfall protein augments neutrophil NETosis during urinary tract infection

Vicki Mercado-Evans, Holly Branthoover, Claude Chew et al. · JCI Insight · 2024 · 12 citations · Full text

, , +16

Early Recovery of Myeloid-Derived Suppressor Cells After Allogeneic Hematopoietic Transplant: Comparison of Post-Transplantation Cyclophosphamide to Standard Graft-Versus-Host Disease Prophylaxis

Benjamin Oshrine, Patrick Innamarato, Holly Branthoover et al. · Transplantation and Cellular Therapy · 2022 · 11 citations

, , +14

1–5 of 5